HIV 1 PCR Qualitative
HIV-1 PCR detects viral RNA in the blood, enabling diagnosis during the window period before antibodies develop. It is the most sensitive test for early HIV-1 detection.
- Free home collection
- Physician-reviewed report
2 to 3 days
Turnaround
Blood
Sample
What the HIV 1 PCR Qualitative test tells you
Where an antibody test asks how your immune system has responded, this test looks for the virus itself. HIV-1 PCR searches a plasma sample for the genetic material of the virus and reports whether it is detected or not detected. Viral genetic material appears before p24 antigen and well before antibodies, which makes it the earliest marker of HIV-1 infection a laboratory can measure.
That gives it three distinct jobs. The first is very early detection, when a possible exposure was recent and waiting for antibodies to develop is not the right approach. The second is resolving an unclear picture: when a screening test has come back reactive and the confirmatory pattern is ambiguous, looking directly for the virus usually settles the question. The third is testing babies born to a parent living with HIV, whose blood carries transferred antibodies for a considerable time and therefore cannot be assessed by antibody testing at all.
This version is qualitative: it reports presence or absence, not quantity. Treatment monitoring uses a quantitative viral load assay, which is a different test measuring how much virus is circulating; that is the number your doctor follows once treatment has started. It also means a not-detected result carries a caveat for anyone already on antiviral treatment or prophylaxis, because effective therapy suppresses the virus below what any assay can find. That suppression is the goal of treatment, and reaching it is what allows people with HIV to live a normal life span and to stop transmitting the virus to sexual partners.
Early detection during the window period, neonatal HIV testing, resolving indeterminate antibody results, and when acute HIV infection is suspected.
- Earliest detectable HIV-1 marker
Viral genetic material appears before antigen and antibody, so this test can identify infection at a stage when antibody screening is still negative.
- Clarifies an unclear screen
When a screening test is reactive and confirmation is ambiguous, looking for the virus directly usually resolves the question quickly.
- Testing infants reliably
Babies born to a parent living with HIV carry transferred antibodies, so only a test for the virus's own genetic material can assess the baby.
- Assessing a recent exposure
Where a possible exposure was recent and a decision cannot wait, this test can give information earlier than any antibody-based approach.
Reasons your doctor may request the HIV 1 PCR Qualitative test
Your doctor may order this test for any of the reasons below. Some are routine checks, others follow specific symptoms or an earlier result.
Recent exposure & early illness
- A recent possible exposure where waiting for antibodies to develop is not the right approach.
- A feverish, flu-like illness with rash, sore throat or swollen glands following a possible exposure.
Confirming a screening result
- A reactive HIV screening test that needs confirmation, or one that has produced an unclear pattern.
Infants & post-exposure care
- A newborn or young infant whose parent is living with HIV.
- Assessment before or shortly after starting post-exposure prophylaxis, on your doctor's advice.
This test looks for HIV-1's own genetic material, so it is reported as "Detected" or "Not Detected", and it can identify infection earlier than antigen or antibody testing. "Detected" means HIV-1 genetic material was found: an acute infection before antibodies have formed, an established infection in someone not on treatment, or virus that is not fully suppressed in someone already on treatment. "Not Detected" means none was found in the sample. Effective antiviral treatment or preventive medication suppresses the virus, so "Not Detected" does not exclude HIV in someone already taking those. The test is qualitative, so treatment is monitored with a quantitative viral load test instead, and it detects HIV-1 only: the other type of HIV needs its own specific test, and someone can carry both. Your doctor interprets the result in confidence, alongside your history and any antibody testing.
HIV 1 PCR Qualitative
This test looks for HIV-1's own genetic material, so it is reported as "Detected" or "Not Detected", and it can identify infection earlier than antigen or antibody testing. "Detected" means HIV-1 genetic material was found: an acute infection before antibodies have formed, an established infection in someone not on treatment, or virus that is not fully suppressed in someone already on treatment. "Not Detected" means none was found in the sample. Effective antiviral treatment or preventive medication suppresses the virus, so "Not Detected" does not exclude HIV in someone already taking those. The test is qualitative, so treatment is monitored with a quantitative viral load test instead, and it detects HIV-1 only: the other type of HIV needs its own specific test, and someone can carry both. Your doctor interprets the result in confidence, alongside your history and any antibody testing.
The target was not detected: a negative result.
The target was detected: a positive result. Please consult your physician.
This test is reported descriptively rather than on a numeric scale: each finding below explains what your report may say.
This information is for general education only and is not medical advice. Reference ranges can vary by laboratory, age, sex, and individual factors. Always consult your physician or doctor to interpret your results.
What a higher result can point to
- Acute HIV-1 infection, before antibodies have had time to form.
- Established HIV-1 infection in someone not currently taking antiviral treatment.
- HIV-1 infection acquired by an infant around the time of birth or through breastfeeding.
- Infection in someone on treatment whose virus is not fully suppressed, for example after interrupted doses or where drug resistance has developed.
These are possibilities, not diagnoses. A single value outside the reference range is interpreted alongside your symptoms, history and other tests: your doctor decides what it means for you.
What this test cannot tell you
- It is qualitative: it reports presence or absence, not the amount of virus, so it cannot be used to monitor how treatment is going.
- Effective antiviral treatment or prophylaxis suppresses the virus, so a not-detected result does not exclude HIV in someone already taking those medicines.
- It detects HIV-1 only; HIV-2 requires its own specific test, and someone can carry both.
- A not-detected result has no separate list of causes of its own: it simply means no HIV-1 genetic material was found in that sample at that moment.
Risks of the blood draw
- Mild bruising or brief soreness where the needle went in.
- Occasional lightheadedness, which settles after a few minutes of rest.
- Bleeding or infection at the site, which is rare with sterile single-use equipment.
- 1Looks for the virus's genetic material rather than the body's response to it.
- 2Detects HIV-1 earlier than antigen or antibody testing can.
- 3Qualitative: detected or not detected, with no measure of quantity: treatment monitoring uses a quantitative viral load test.
- 4It is the appropriate test for infants, whose antibody results reflect the parent's immunity rather than their own.
- 5Results are confidential and are interpreted alongside your history and any antibody testing.
- STI & STDHIV 1 & 2 Antibodies with P24 Antigen
This fourth-generation HIV test detects both HIV antibodies and the p24 antigen, enabling earlier detection than antibody-only tests: typically…
220View - STI & STDHIV 2 PCR Qualitative
HIV-2 PCR specifically detects HIV-2 viral RNA. It is used when HIV-2 infection is suspected, particularly in individuals from or with connections to…
549View - STI & STDRPR (Rapid Plasma Reagin)
RPR is a screening test for syphilis that detects antibodies to tissue damage caused by the bacterium Treponema pallidum. A positive result requires…
170View
Frequently Asked Questions
Everything you need to know about the HIV 1 PCR Qualitative test. Can't find what you're looking for?
Talk to our team→The screening test looks for your immune system's response and for a viral protein, and it takes some time after infection to become reactive. This test looks for the virus's genetic material, which appears first. They answer related but different questions, and are often used together.
It means no HIV-1 genetic material was found in that sample. If a possible exposure was very recent, or if you are taking antiviral prophylaxis or treatment, your doctor may still recommend follow-up testing before drawing a conclusion.
No. This version answers only whether the virus is present. Measuring how much virus is circulating needs a quantitative viral load assay, and that is the test used to follow treatment over time.
Antibodies cross the placenta, so a baby born to a parent with HIV will test antibody-positive whether or not the baby is infected. Looking for the virus's own genetic material avoids that ambiguity and gives a clear answer.
HIV-1 PCR detects viral RNA in the blood, enabling diagnosis during the window period before antibodies develop. It is the most sensitive test for early HIV-1 detection.
Early detection during the window period, neonatal HIV testing, resolving indeterminate antibody results, and when acute HIV infection is suspected.
No, fasting is not required for the HIV-1 Viral RNA test, so you can eat and drink normally beforehand.
The HIV-1 Viral RNA test uses a edta plasma sample, collected quickly by our DHA-licensed phlebotomist with minimal discomfort.
Results for the HIV-1 Viral RNA test are typically ready within 2 to 3 days. You will receive a secure digital report, and your Smart Report highlights anything outside the normal range.
The HIV-1 Viral RNA test is AED 549, which includes free home sample collection and a physician-reviewed report. You can also build a custom panel and pay only for the markers you choose.
Yes. A DHA-licensed phlebotomist can collect your sample at home or the office anywhere in Dubai at no extra cost, 7 days a week. See how it works.
It is commonly chosen by sexually active adults. If you are not sure it is right for you, our care team is happy to advise.
Add the HIV-1 Viral RNA test to your cart and complete the short booking wizard, choosing home collection or a lab visit. Guest checkout lets you book without creating an account.
Yes. It is processed at our EIAC-accredited laboratory (ISO 15189:2022) under DHA license 0046381 and verified by board-certified pathologists.
Every report includes reference ranges and plain-language notes. If you have questions, our care team can arrange a clinician review: just get in touch.
Absolutely. Add it to a curated health package or bundle it with any of our 160+ biomarkers, often from a single sample in one visit.